When should we use nitrates in congestive heart failure? 2013

Enrico Vizzardi, and Ivano Bonadei, and Riccardo Rovetta, and Antonio D'Aloia, and Filippo Quinzani, and Antonio Curnis, and Livio Dei Cas
Section of Cardiovascular Diseases, Department of Experimental and Applied Medicine, University of Study of Brescia, Brescia, Italy. enrico.vizzardi@tin.it

Organic nitrates remain among the oldest and most commonly employed drugs in cardiology. Although, in most cases, their use in acute and chronic heart failure is based on clinical practice, only a few clinical trials have been conducted to evaluate their use in acute and chronic heart failure, most of which compare them with other drugs to evaluate differing endpoints. The purpose of this review is to examine the various trials that have evaluated the use of nitrates in acute and chronic heart failure.

UI MeSH Term Description Entries
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009566 Nitrates Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. Nitrate
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator
D016276 Ventricular Function The hemodynamic and electrophysiological action of the HEART VENTRICLES. Function, Ventricular,Functions, Ventricular,Ventricular Functions
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Enrico Vizzardi, and Ivano Bonadei, and Riccardo Rovetta, and Antonio D'Aloia, and Filippo Quinzani, and Antonio Curnis, and Livio Dei Cas
July 1979, Modern concepts of cardiovascular disease,
Enrico Vizzardi, and Ivano Bonadei, and Riccardo Rovetta, and Antonio D'Aloia, and Filippo Quinzani, and Antonio Curnis, and Livio Dei Cas
March 1989, The Medical clinics of North America,
Enrico Vizzardi, and Ivano Bonadei, and Riccardo Rovetta, and Antonio D'Aloia, and Filippo Quinzani, and Antonio Curnis, and Livio Dei Cas
June 1994, Cardiovascular drugs and therapy,
Enrico Vizzardi, and Ivano Bonadei, and Riccardo Rovetta, and Antonio D'Aloia, and Filippo Quinzani, and Antonio Curnis, and Livio Dei Cas
July 1985, The American journal of cardiology,
Enrico Vizzardi, and Ivano Bonadei, and Riccardo Rovetta, and Antonio D'Aloia, and Filippo Quinzani, and Antonio Curnis, and Livio Dei Cas
January 1987, Drugs,
Enrico Vizzardi, and Ivano Bonadei, and Riccardo Rovetta, and Antonio D'Aloia, and Filippo Quinzani, and Antonio Curnis, and Livio Dei Cas
November 1987, The American journal of cardiology,
Enrico Vizzardi, and Ivano Bonadei, and Riccardo Rovetta, and Antonio D'Aloia, and Filippo Quinzani, and Antonio Curnis, and Livio Dei Cas
January 1980, Heart & lung : the journal of critical care,
Enrico Vizzardi, and Ivano Bonadei, and Riccardo Rovetta, and Antonio D'Aloia, and Filippo Quinzani, and Antonio Curnis, and Livio Dei Cas
May 1996, The American journal of cardiology,
Enrico Vizzardi, and Ivano Bonadei, and Riccardo Rovetta, and Antonio D'Aloia, and Filippo Quinzani, and Antonio Curnis, and Livio Dei Cas
November 1993, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,
Enrico Vizzardi, and Ivano Bonadei, and Riccardo Rovetta, and Antonio D'Aloia, and Filippo Quinzani, and Antonio Curnis, and Livio Dei Cas
January 1993, Coronary artery disease,
Copied contents to your clipboard!